L’Agence nationale de sécurité du médicament a annoncé une série de mesures afin de gérer ces difficultés d’approvisionnement, causées par un problème de production rencontré par le fabricant grec Pharmathen.
Source link : https://www.lemonde.fr/economie/article/2025/01/30/psychiatrie-les-traitements-a-base-de-quetiapine-touches-par-une-penurie_6524251_3234.html
Author :
Publish date : 2025-01-30 22:27:00
Copyright for syndicated content belongs to the linked Source.
Trending
- El Senado cuela como enmienda la rebaja de la protección del lobo en la ley de desperdicio alimentario
- Localizan un ‘enjambre sísmico’ de 11 terremotos en el volcán de Enmedio, entre Tenerife y Gran Canaria
- Perv who lied about his age to lure in young girls and get them drunk is jailed
- Maradona ‘condemned to oblivion’ by healthcare staff, Argentinian court hears
- DOJ official dismissed after she refused to reinstate gun rights for Trump ally Mel Gibson: Report
- Harry Maguire Greek court case latest five years after his original conviction
- Heartwarming ‘meaning behind Michelle Keegan and Mark Wright’s unique baby name’ revealed
- From Mexico cartel safe house to US streets: BBC tracks deadly fentanyl targeted by Trump tariffs
Wednesday, March 12